Tag Archives: Rosuvastatin
March 2008 Br J Cardiol 2008;15:95-100
A UK survey of rosuvastatin in general practice: reaching cholesterol targets
George Kassianos, John Reckless, Cathy Emmas, Marc Evans, Andrea Tree, Andrew Vance
Introduction Coronary heart disease (CHD) is responsible for over 100,000 deaths annually in the UK.1 Epidemiology studies have long supported that cholesterol is a key risk factor for cardiovascular disease (CVD).2 In both primary and secondary prevention, statin therapy trials have shown that there is a clear relationship between lowering cholesterol and reducing cardiovascular risk in both primary and secondary prevention.3 However, The World Health Report 2002 estimates that over 50% of CHD globally is still due to elevated blood cholesterol levels.4 Table 1. Recommended targets for total cholesterol (TC) and low-density lipoprotein chol
March 2006 Br J Cardiol 2006;13:90-8
American College of Cardiology 55th Annual Scientific Session
BJCardio editorial team
No content available
January 2003 Br J Cardiol 2003;10:59-68
Current progress in lipid therapy
Rubin Minhas
No content available
For healthcare professionals only
